Genomic sequencing to screen newborns raises more false alarms than routine blood tests

STAT |
August 2020
Press

In this study led by UCSF researchers, exome sequencing was found to produce more false positives and false negatives for inherited metabolic disorders than the standard blood testing conducted in newborns. G2P’s Dr. Robert Green, co-leader of the BabySeq Project, speaks to the possibility “that the most comprehensive screening for newborns will be some combination … Continued

The Project Baseline Health Study: A step towards a broader mission to map human health

Gambhir S, Arges K, Assimes T, Bajaj V, Balu S, Bashir M, Beskow L, Blanco R, Califf R, Campbell P, Carin L, Christian V, Cousins S, Das M, Dockery M, Douglas P, Dunham A, Eckstrand J, Fleischmann D, Ford E, Fraulo E, French J, Ginsburg G, Green R... Shipes S, Sledge G, Spielman S, Spitler R, Schaack T, Swamy G, Willemink M, and Wong C
npj Digital Medicine June 2020  

Geneticist says DNA testing should be part of everyday healthcare

CNBC |
May 2020
Press, Video

Dr. Robert Green is the director of the Preventive Genomics Clinic at Brigham and Women’s Hospital in Boston. He believes that DNA testing combined with proper counseling and medical follow-up would be a critical element of a healthcare system that can prevent illness.

Clinical utility of genomic sequencing: A measurement toolkit

Hayeems RZ, Dimmock D, Bick D, Belmont JW, Green RC, Lanpher B, Jobanputra V, Mendoza R, Kulkarni S, Grove ME, Taylor SL, Ashley E
npj Genomic Medicine In Press

Coronavirus: Genes may explain why some face greater danger than others

Fox News |
April 2020
Press

“While healthy young people as a group are less likely to have severe symptoms with COVID, they have to understand that some of them will become very ill and will even die from this infection,” Dr. Robert Green said. “No one should assume youth makes them invulnerable.”

Of Known Significance

Clinical Omics |
March 2020
Press

An exclusive Clinical OMICs conversation with the director of Genomes2People, Robert Green, M.D., MPH

All in for All of Us

Brigham Clinical and Research News |
March 2020
Press

Through national research efforts like the All of Us Research Program, Brigham investigators and their collaborators are making genomic research more meaningful, equitable and impactful for all patients at the Brigham and around the world.

Econogenomics: The economics of genomic testing for health

Medium |
January 2020
G2P Blog

“The cost of sequencing itself is already comparable to a lot of other diagnostic tests regularly used in medicine,” Kurt Christensen, PhD said. Besides: “What really moves the needle on cost effectiveness isn’t the costs — it’s the benefits.”

Reset your DNA to slow the clock

Neo Life |
December 2019
Press

A new epigenetic test that tracks molecular aging claims to show you how to stay biologically young. However, Robert Green says “epigenetic marks in apparently healthy people can tell them meaningful things about their health status is an overreach.”

Apple is offering free genetic tests to all its Silicon Valley employees

CNBC |
December 2019
Press

“It’s really exciting that to see companies move to preserve health, rather than just treating patients when they’re ill,” said Dr. Robert Green, a medical geneticist at Harvard Medical School and a co-founder of a genetics company called Genome Medical.

Addressing barriers to expanding genetic counseling

Modern Health Care |
November 2019
Press

Genetic counselors are becoming a bigger part of the healthcare continuum as population health management seeks to more quickly screen for, assess and prevent illness. Read on as genetic counselors in the field, including our own, Carrie Blout, address some of the barriers in genetic counseling.

China’s genetics giant wants to tailor medicine to your DNA

Bloomberg |
November 2019
Press

BGI is racing toward a world where your DNA informs your medical decisions—and maybe some of your personal ones. Bloomberg asks Dr. Robert Green on his thoughts regarding the medical advances in genomics in China and how they compare to those in the US.

Is preventive genomics elitist?

Medium |
October 2019
G2P Blog

The ultimate aim of our Genomes2People Research Program is to contribute to the transformation of medicine from reactive to proactive, from treatment-oriented to preventive. We are trying to help build the evidence base that will justify societal decision to make these technologies and services accessible to anyone who wants them, regardless of means, education or … Continued